Baseline characteristics in relation to clinical outcome
VAS Score ≤3 | VAS Score >3 | P Value | |
---|---|---|---|
No. of patients | 57 | 38 | |
Age (yr) | 77.7 ± 8.0 | 80.6 ± 8.6 | .30 |
Female sex (%) | 37 (57) | 28 (61) | .41 |
Duration of back pain (days) | 29.3 ± 17.1 | 26.8 ± 16.0 | .46 |
VAS | 7.4 ± 1.5 | 7.9 ± 1.4 | .08 |
RMD score | 17.8 ± 3.7 | 16.9 ± 4.5 | .32 |
Number of VCFs | 2.1 ± 1.5 | 2.2 ± 1.5 | .97 |
Genant et al6 | |||
Grade 1 | 24 | 12 | .87 |
Grade 2 | 19 | 12 | |
Grade 3 | 22 | 7 | |
Wedge | 46 | 29 | .48 |
Biconcave | 8 | 7 | |
Crush | 0 | 0 | |
Bone density (t-score) | −3.0 ± 1.17 | −3.0 ± 1.02 | .44 |